A pilot study of safety, effectiveness, and adherence of lamivudine/zidovudine and efavirenz (3TC/ZDV + EFV) to treat HIV-1 infection in Senegal.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Efavirenz (Primary) ; Lamivudine/zidovudine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 23 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2008 Planned end date changed from 1 Jun 2008 to 1 Jun 2008 according to the ClinicalTrials.gov record.